Universe Pharmaceuticals (UPC) Payables: 2020-2024
- Universe Pharmaceuticals' Payables rose 6.99% to $10.8 million in Q3 2024 from the same period last year, while for Sep 2024 it was $29.3 million, marking a year-over-year increase of 14.79%. This contributed to the annual value of $10.8 million for FY2024, which is 6.99% up from last year.
- Per Universe Pharmaceuticals' latest filing, its Payables stood at $10.8 million for Q3 2024, which was up 143.04% from $4.4 million recorded in Q1 2024.
- In the past 5 years, Universe Pharmaceuticals' Payables ranged from a high of $2,646.0 billion in Q3 2020 and a low of $4.1 million during Q1 2023.
- Moreover, its 3-year median value for Payables was $5.7 million (2022), whereas its average is $6.8 million.
- As far as peak fluctuations go, Universe Pharmaceuticals' Payables slumped by 100.00% in 2021, and later skyrocketed by 43.59% in 2023.
- Over the past 5 years, Universe Pharmaceuticals' Payables (Quarterly) stood at $2,646.0 billion in 2020, then plummeted by 100.00% to $9.6 million in 2021, then declined by 27.30% to $7.0 million in 2022, then skyrocketed by 43.59% to $10.1 million in 2023, then rose by 6.99% to $10.8 million in 2024.
- Its Payables stands at $10.8 million for Q3 2024, versus $4.4 million for Q1 2024 and $10.1 million for Q3 2023.
